Drug Approval | August 12, 2025
Boehringer’s lung cancer medicine gets FDA approval
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
Athena is also exploring the use of this technology for expanded carrier screening
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
Subscribe To Our Newsletter & Stay Updated
